InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-43.0%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Berkowitz Jeffrey, Director. Officer active across 1 company, notably Esperion Therapeutics, Inc.. Aggregated, 2 disclosures have been recorded. Activity tracked since 27 May 2021. The latest transaction was disclosed on 27 May 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations2 total
12,376 shares0Common StockSEC:0001628280-21-011362:0
12,376 shares0Common StockSEC:0001628280-21-011362
2 of 2 declarations
About Berkowitz Jeffrey
Jeffrey Berkowitz is a Director at Esperion Therapeutics, Inc. He contributes to corporate governance and the company's strategy. His role is essential for guiding the board's decisions in the biopharmaceutical sector.
